2019-12-26 |
2019-12-24 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
15.476
-0.6%
19,59
303.175
USD
|
15.476
-0.6%
|
19,59
|
303.175
USD
|
|
2019-12-26 |
2019-12-24 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
48.324
-0.6%
19,59
946.667
USD
|
48.324
-0.6%
|
19,59
|
946.667
USD
|
|
2019-12-26 |
2019-12-23 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
10.400
-17.4%
19,82
206.128
USD
|
10.400
-17.4%
|
19,82
|
206.128
USD
|
|
2019-12-26 |
2019-12-23 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
20.350
-0.8%
19,82
403.337
USD
|
20.350
-0.8%
|
19,82
|
403.337
USD
|
|
2019-12-26 |
2019-12-23 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
63.535
-0.8%
19,82
1.259.264
USD
|
63.535
-0.8%
|
19,82
|
1.259.264
USD
|
|
2019-12-26 |
2019-12-20 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
37.900
-38.8%
19,66
745.114
USD
|
37.900
-38.8%
|
19,66
|
745.114
USD
|
|
2019-12-26 |
2019-12-20 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
73.879
-2.7%
19,66
1.452.461
USD
|
73.879
-2.7%
|
19,66
|
1.452.461
USD
|
|
2019-12-26 |
2019-12-20 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
230.721
-2.7%
19,66
4.535.975
USD
|
230.721
-2.7%
|
19,66
|
4.535.975
USD
|
|
2019-12-19 |
2019-12-17 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
105.500
-51.9%
18,52
1.953.860
USD
|
105.500
-51.9%
|
18,52
|
1.953.860
USD
|
|
2019-12-19 |
2019-12-17 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
205.793
-6.9%
18,52
3.811.286
USD
|
205.793
-6.9%
|
18,52
|
3.811.286
USD
|
|
2019-12-19 |
2019-12-17 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
642.807
-6.9%
18,52
11.904.786
USD
|
642.807
-6.9%
|
18,52
|
11.904.786
USD
|
|
2019-12-17 |
2019-12-13 |
GV
Geplanter Verkauf
|
Paul Robert
Chief Medical Officer
Führungsperson
|
10.000
-3.4%
20,03
200.300
USD
|
10.000
-3.4%
|
20,03
|
200.300
USD
|
|
2019-12-16 |
2019-12-12 |
GV
Geplanter Verkauf
|
Oney Sabah
Chief Business Officer
Führungsperson
|
6.810
-1.1%
20,13
137.069
USD
|
6.810
-1.1%
|
20,13
|
137.069
USD
|
|
2019-12-12 |
2019-12-10 |
GV
Geplanter Verkauf
|
Oney Sabah
Chief Business Officer
Führungsperson
|
500
-0.1%
20,01
10.005
USD
|
500
-0.1%
|
20,01
|
10.005
USD
|
|
2019-12-09 |
2019-12-09 |
GV
Geplanter Verkauf
|
Oney Sabah
Chief Business Officer
Führungsperson
|
2.300
-0.4%
20,07
46.161
USD
|
2.300
-0.4%
|
20,07
|
46.161
USD
|
|
2019-12-09 |
2019-12-06 |
GV
Geplanter Verkauf
|
Oney Sabah
Chief Business Officer
Führungsperson
|
5.156
-0.9%
20,02
103.223
USD
|
5.156
-0.9%
|
20,02
|
103.223
USD
|
|
2019-12-09 |
2019-12-05 |
GV
Geplanter Verkauf
|
Oney Sabah
Chief Business Officer
Führungsperson
|
1.500
-0.3%
20,00
30.000
USD
|
1.500
-0.3%
|
20,00
|
30.000
USD
|
|
2019-12-05 |
2019-12-03 |
GV
Geplanter Verkauf
|
Yu Calvin
Vice President, Finance
Führungsperson
|
1.315
-0.7%
18,31
24.078
USD
|
1.315
-0.7%
|
18,31
|
24.078
USD
|
|
2019-11-19 |
2019-11-15 |
GV
Geplanter Verkauf
|
Paul Robert
Chief Medical Officer
Führungsperson
|
10.000
-3.3%
15,93
159.300
USD
|
10.000
-3.3%
|
15,93
|
159.300
USD
|
|
2019-11-19 |
2019-11-15 |
GV
Geplanter Verkauf
|
King Robert
Chief Development Officer
Führungsperson
|
7.500
-1.4%
15,92
119.400
USD
|
7.500
-1.4%
|
15,92
|
119.400
USD
|
|
2019-10-17 |
2019-10-15 |
GV
Geplanter Verkauf
|
Paul Robert
Chief Medical Officer
|
10.000
-3.2%
14,68
146.800
USD
|
10.000
-3.2%
|
14,68
|
146.800
USD
|
|
2019-09-24 |
2019-09-20 |
GV
Geplanter Verkauf
|
Oney Sabah
Chief Business Officer
|
400
-0.1%
20,00
8.000
USD
|
400
-0.1%
|
20,00
|
8.000
USD
|
|
2019-09-24 |
2019-09-20 |
GV
Geplanter Verkauf
|
Paul Robert
Chief Medical Officer
|
4.000
-1.3%
20,00
80.000
USD
|
4.000
-1.3%
|
20,00
|
80.000
USD
|
|
2019-09-18 |
2019-09-16 |
GV
Geplanter Verkauf
|
Paul Robert
Chief Medical Officer
|
10.000
-3.1%
19,08
190.800
USD
|
10.000
-3.1%
|
19,08
|
190.800
USD
|
|
2019-08-21 |
2019-08-20 |
GV
Geplanter Verkauf
|
Paul Robert
Chief Medical Officer
Führungsperson
|
916
-0.3%
16,00
14.656
USD
|
916
-0.3%
|
16,00
|
14.656
USD
|
|
2019-08-21 |
2019-08-19 |
GV
Geplanter Verkauf
|
Paul Robert
Chief Medical Officer
Führungsperson
|
1.084
-0.3%
16,00
17.344
USD
|
1.084
-0.3%
|
16,00
|
17.344
USD
|
|
2019-08-21 |
2019-08-19 |
GV
Geplanter Verkauf
|
King Robert
Chief Development Officer
Führungsperson
|
7.500
-1.4%
15,00
112.500
USD
|
7.500
-1.4%
|
15,00
|
112.500
USD
|
|
2019-08-19 |
2019-08-15 |
GV
Geplanter Verkauf
|
Paul Robert
Chief Medical Officer
Führungsperson
|
10.000
-3.0%
14,19
141.900
USD
|
10.000
-3.0%
|
14,19
|
141.900
USD
|
|
2019-08-09 |
2019-08-07 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
157.636
-5.0%
17,90
2.821.684
USD
|
157.636
-5.0%
|
17,90
|
2.821.684
USD
|
|
2019-08-09 |
2019-08-07 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
492.364
-5.0%
17,90
8.813.316
USD
|
492.364
-5.0%
|
17,90
|
8.813.316
USD
|
|
2019-02-11 |
2019-02-11 |
K
Kauf
|
GORDON CARL L
Nicht geschäftsführender Verwaltungsratsmitglied
Large shareholder
|
203.200
+inf%
19,00
3.860.800
USD
|
203.200
+inf%
|
19,00
|
3.860.800
USD
|
|
2019-02-11 |
2019-02-11 |
K
Kauf
|
GORDON CARL L
Nicht geschäftsführender Verwaltungsratsmitglied
Large shareholder
|
50.561
+2.1%
19,00
960.659
USD
|
50.561
+2.1%
|
19,00
|
960.659
USD
|
|
2019-02-11 |
2019-02-11 |
K
Kauf
|
GORDON CARL L
Nicht geschäftsführender Verwaltungsratsmitglied
Large shareholder
|
157.939
+1.5%
19,00
3.000.841
USD
|
157.939
+1.5%
|
19,00
|
3.000.841
USD
|
|
2019-02-11 |
2019-02-11 |
K
Kauf
|
ORBIMED ADVISORS LLC
Nicht geschäftsführender Verwaltungsratsmitglied
Large shareholder
|
203.200
+inf%
19,00
3.860.800
USD
|
203.200
+inf%
|
19,00
|
3.860.800
USD
|
|
2019-02-11 |
2019-02-11 |
K
Kauf
|
ORBIMED ADVISORS LLC
Nicht geschäftsführender Verwaltungsratsmitglied
Large shareholder
|
50.561
+2.1%
19,00
960.659
USD
|
50.561
+2.1%
|
19,00
|
960.659
USD
|
|
2019-02-11 |
2019-02-11 |
K
Kauf
|
ORBIMED ADVISORS LLC
Nicht geschäftsführender Verwaltungsratsmitglied
Large shareholder
|
157.939
+1.5%
19,00
3.000.841
USD
|
157.939
+1.5%
|
19,00
|
3.000.841
USD
|
|